Patients' Preferences for Adjuvant Osimertinib in Non-Small-Cell Lung Cancer After Complete Surgical Resection: What Makes It Worth It to Patients? - Awidi M; Mier-Hicks A; Perimbeti S; Attwood K; Chen H; Jain P; Yau E; Early A; Dy GK (Clinical lung cancer, 2024)